Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on July 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

BRAND NAME AGILENT OPENLAB CDS AND ECM SOFTWARE MAINTENANCE

Closed
75F40126Q00330Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Office of Pharmaceutical Quality Research within the FDA requires a maintenance service contract for the Agilent OpenLab CDS and ECM software systems, which are critical to daily analytical operations including HPLC control, chromatographic data analysis, and regulatory study support. The contract, solicited under number 75F40126Q00330, is a firm-fixed price agreement with a base period running from September 11, 2026, to September 10, 2027, and includes an option to extend for an additional year, not to exceed two years total. The scope encompasses delivery of the OpenLab ECM Enterprise Server Software, 32 named user licenses for St. Louis and 50 for Silver Spring, instrument connectivity, LCMS QQQ Mass Hunter Software, access control software, and accompanying Installation and Operational Qualification reports—all required to meet Section 508 accessibility standards and related EIT requirements. Deliveries are to be made to designated government locations in St. Louis, Missouri, and Silver Spring, Maryland, with services performed virtually. All items must conform to the solicitation’s salient characteristics and are subject to government inspection and acceptance at the delivery sites. The evaluation will be conducted on a Lowest Priced Technically Acceptable basis, where only technically compliant offers will be considered and award will go to the lowest-priced qualified submitter. The contract incorporates numerous FAR clauses including those on payment via electronic funds transfer and government purchase card, contractor ethics, cybersecurity safeguards, privacy training, prohibitions on certain telecommunications equipment, service labor standards, paid sick leave, and whistleblower protections. Offerors must maintain current SAM registration with a valid UEI and comply with Buy American and trade agreement requirements. Pricing details are not provided in the solicitation, and the total contract value is not specified, though all bids must include complete, unambiguous pricing for all deliverables. The primary point of contact for the solicitation is Tiffany Hatcher, with final contract administration roles to be assigned upon award.

General Info

Maintenance contract for Agilent software to ensure uninterrupted chromatographic data analysis for pharmaceutical quality research.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

0, MD, USA

Set-Aside

NONE

Documents

(2)

Amendment 1 to RFQ 75F40126Q00330 for Agilent OpenLab Software Maintenance

PDFamendment

RFQ 75F40126Q00330 - Agilent OpenLab CDS and ECM Software Maintenance

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Combined Synopsis

Amendment 1

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA

Full Description

Show more

The Office of Pharmaceutical Quality Research (OPQR) is a CDER laboratory-based office that utilizes broad range of analytical methods and computer modeling to conduct research to evaluate the product and process design their impact on product quality. 



The Agilent OpenLab CDS (Chromatography Data System) and ECM (Enterprise Content Management) system currently in use at the Office of Pharmaceutical Quality Research (OPQR) needs a service contract to ensure that software is updated, and all reported problems are properly addressed. Agilent OpenLab CDS and ECM system is used on a daily basis in conjunction with various research and regulatory studies performed at OPQR.  It is the principal software used to control HPLC systems and to analyze and save chromatographic data.  Therefore, it is critical to the Office’s mission.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS